Proton pump inhibitors and fracture risk: response to comments

Osteoporos Int. 2016 Apr;27(4):1673-1674. doi: 10.1007/s00198-015-3434-1. Epub 2015 Nov 24.

Authors

B Zhou¹, Y Huang¹, H Li¹, W Sun¹, J Liu²

Affiliations

¹ Jiangsu Center for Safety Evaluation of Drugs, School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing, 210009, China.
² Jiangsu Center for Safety Evaluation of Drugs, School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing, 210009, China. jansens2004@sina.com.

PMID: 26602916
DOI: 10.1007/s00198-015-3434-1

No abstract available

Publication types

Letter
Comment

MeSH terms

Fractures, Bone*
Humans
Proton Pump Inhibitors*
Risk

Substances

Proton Pump Inhibitors